Literature DB >> 18983216

Drug-induced gynecomastia.

Ari Eckman1, Adrian Dobs.   

Abstract

Gynecomastia is caused by drugs in 10 - 25% of all cases. The pathophysiologic mechanism for some drugs includes exogenous estrogens exposure, medications that cause hypogonadism, anti-androgenic effects and hyperprolactinemia. This manuscript reviews common examples of drug-induced gynecomastia, discussing the mechanisms and possible treatments. Discontinuing the medication is always the best choice; however, if this is not possible, then testosterone replacement therapy may be needed for hypogonadism. When a man is euogonadal, a trial of the anti-estrogen, tamoxifen or an aromatase inhibitor may be an option.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983216     DOI: 10.1517/14740330802442382

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  21 in total

Review 1.  Bilateral masculine mastoplasia associated with imatinib mesylate: a case report and literature review.

Authors:  Dan Zhao; Gaoxiang Wang; Chunrui Li; Li Meng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

2.  The Role of Estrogen Modulators in Male Hypogonadism and Infertility.

Authors:  Amarnath Rambhatla; Jesse N Mills; Jacob Rajfer
Journal:  Rev Urol       Date:  2016

3.  Who Gets Severe Gynecomastia Among HIV-infected Children in the United Kingdom and Ireland?

Authors:  Julia Kenny; Katja Doerholt; Di M Gibb; Ali Judd
Journal:  Pediatr Infect Dis J       Date:  2017-03       Impact factor: 2.129

4.  Drug-induced gynecomastia in children and adolescents.

Authors:  Ran D Goldman
Journal:  Can Fam Physician       Date:  2010-04       Impact factor: 3.275

5.  Fluoxymesterone-induced gynaecomastia in a patient with childhood aplastic anaemia.

Authors:  Tom Edward Ngo Lo; Zillien C Andal; Frances Lina Lantion-Ang
Journal:  BMJ Case Rep       Date:  2015-05-06

6.  Class III gynecomastia in pediatric age: a new modified surgical treatment.

Authors:  Nicola Zampieri; Roberto Castellani; Stefano Modena; Francesco Saverio Camoglio
Journal:  Pediatr Surg Int       Date:  2012-08-08       Impact factor: 1.827

7.  Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis.

Authors:  M A Tunio; M Al-Asiri; A Al-Amro; Y Bayoumi; M Fareed
Journal:  Curr Oncol       Date:  2012-08       Impact factor: 3.677

8.  Onset of male gynaecomastia in a patient treated with sunitinib for metastatic renal cell carcinoma.

Authors:  Pierluigi Ballardini; Guido Margutti; Camillo Aliberti; Roberto Manfredini
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 9.  Gynecomastia and hormones.

Authors:  Andrea Sansone; Francesco Romanelli; Massimiliano Sansone; Andrea Lenzi; Luigi Di Luigi
Journal:  Endocrine       Date:  2016-05-04       Impact factor: 3.633

10.  α1-Adrenergic receptor antagonists and gynecomastia. A case series from the Italian spontaneous reporting system and VigiBase(™).

Authors:  Ermelinda Viola; Sibilla Opri; Ugo Moretti; Roberto Leone; Maria Luisa Casini; Sara Ruggieri; Claudia Minore; Anita Conforti
Journal:  Eur J Clin Pharmacol       Date:  2014-06-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.